表紙
市場調查報告書

新生兒篩檢(NBS)的全球市場 - 產業趨勢與預測

Global Newborn Screening Market - Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 915584
出版日期 內容資訊 英文 207 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
新生兒篩檢(NBS)的全球市場 - 產業趨勢與預測 Global Newborn Screening Market - Industry Trends and Forecast to 2026
出版日期: 2019年10月01日內容資訊: 英文 207 Pages
簡介

本報告提供全球新生兒篩檢(NBS)市場調查,提供市場概要,各檢驗類型·產品類型·技術·疾病類型·終端用戶·各地區的市場規模的變化與預測(過去2年·今後7年份),市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

第1章 簡介

第2章 市場區隔

第3章 市場概要

第4章 摘要整理

第5章 重要考察

第6章 全球新生兒篩檢(NBS)市場:各檢驗類型

  • 市場概要
  • 乾燥血液地點檢驗(DBS)
  • 聽力檢驗
  • 重病先天性心臟病(CCHD)檢驗

第7章 全球新生兒篩檢(NBS)市場:各產品類型

  • 市場概要
  • 檢驗設備
    • 疾病檢驗設備
    • 聽力檢驗設備
    • 脈動式血氧監測儀系統
  • 試劑·化驗套件

第8種 全球新生兒篩檢(NBS)市場:各技術

  • 市場概要
  • 串聯式質譜分析
  • 聽覺篩檢
  • 脈搏血氧計篩檢
  • 免疫測量 & 酵素化驗
  • 電泳
  • DNA為基礎的化驗

第9章 全球新生兒篩檢(NBS)市場:各疾病類型

  • 市場概要
  • 重病先天性心臟病(CCHD)
  • 嬰幼兒聽障
  • 鐮狀細胞貧血
  • 苯酮尿症(PKU)
  • 囊狀纖維化症(CF)
  • 楓糖漿尿症
  • 其他

第10章 全球新生兒篩檢(NBS)市場:各終端用戶

  • 市場概要
  • 醫院
  • 小兒科診所
  • 診療所

第11章 全球新生兒篩檢(NBS)市場:各地區

  • 市場概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 瑞士
    • 荷蘭
    • 俄羅斯
    • 土耳其
    • 比利時
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 越南
    • 其他
  • 南美
    • 巴西
    • 其他
  • 中東·非洲

第12章 企業概要

  • 企業佔有率分析:全體
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第13章 企業簡介

  • PERKINELMER INC.
  • NATUS MEDICAL INCORPORATED
  • TRIVITRON HEALTHCARE
  • BAEBIES, INC.
  • BIO-RAD LABORATORIES, INC.
  • DANAHER
  • HILL-ROM SERVICES INC.
  • INTELLIGENT HEARING SYSTEMS
  • INTERACOUSTICS A/S
  • MASIMO
  • MEDTRONIC
  • OTODYNAMICS LTD
  • VIVASONIC INC.
  • ZENTECH S.A.

第14章 調查詢問調查

第15章 相關報告

目錄

Global newborn screening market is projected to register a healthy CAGR of 10.7% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa)

Some of the major factors contributing to the growth of the market:

  • Rising prevalence of newborn screening and growth in neonatal diseases
  • Technological advancements in screening and increased government initiatives

Market Players:

The key market players for global newborn screening market are listed below:

  • PerkinElmer Inc.
  • Natus Medical Incorporated
  • Trivitron Healthcare
  • Baebies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danahar
  • Hill-Rom Services Inc.
  • Intelligent Hearing Systems
  • Interacoustics A/S
  • Masimo
  • Medtronic
  • Otodynamics Ltd
  • Vivosonic Inc.
  • ZenTech S.A.
  • Others

TABLE OF CONTENTS

1 INTRODUCTION 22

  • 1.1 OBJECTIVES OF THE STUDY 22
  • 1.2 MARKET DEFINITION 22
  • 1.3 OVERVIEW OF GLOBAL NEWBORN SCREENING MARKET 22
  • 1.4 LIMITATIONS 23
  • 1.5 CURRENCY AND PRICING 23
  • 1.6 MARKETS COVERED 24

2 MARKET SEGMENTATION 26

  • 2.1 MARKETS COVERED 26
  • 2.2 GEOGRAPHICAL SCOPE 27
  • 2.3 YEARS CONSIDERED FOR THE STUDY 28
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 29
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
  • 2.6 SECONDARY SOURCES 33
  • 2.7 ASSUMPTIONS 33

3 MARKET OVERVIEW 34

  • 3.1 DRIVERS 36
    • 3.1.1 RISING PREVALENCE OF NEWBORN SCREENING 36
    • 3.1.2 GROWTH IN NEONATAL DISEASES 38
    • 3.1.3 INCREASED GOVERNMENT INITIATIVES 40
    • 3.1.4 TECHNOLOGICAL ADVANCEMENTS IN SCREENING 41
  • 3.2 RESTRAINTS 42
    • 3.2.1 STRINGENT REGULATORY POLICIES 42
    • 3.2.2 HIGH COST OF AUTOMATED DEVICES 43
  • 3.3 OPPORTUNITIES 44
    • 3.3.1 NEXT-GENERATION SEQUENCING TECHNOLOGY FOR NEWBORN SCREENING 44
    • 3.3.2 EMERGING MARKET 44
  • 3.4 CHALLENGES 46
    • 3.4.1 SOCIO ECONOMIC BARRIERS 46
    • 3.4.2 LACK OF SKILLED PROFESSIONALS 46

4 EXECUTIVE SUMMARY 47

5 PREMIUM INSIGHTS 50

6 GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE 53

  • 6.1 OVERVIEW 54
  • 6.2 DRIED BLOOD SPOT TEST 55
  • 6.3 HEARING SCREEN TEST 56
  • 6.4 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST 57

7 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE 58

  • 7.1 OVERVIEW 59
  • 7.2 INSTRUMENTS 60
    • 7.2.1 NEWBORN DISORDER SCREENING INSTRUMENTS 60
    • 7.2.2 NEWBORN HEARING SCREENING INSTRUMENTS 61
    • 7.2.3 PULSE OXIMETER 61
  • 7.3 REAGENTS AND ASSAY KITS 61

8 GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY 62

  • 8.1 OVERVIEW 63
  • 8.2 TANDEM MASS SPECTROMETRY 64
  • 8.3 HEARING SCREEN TECHNOLOGY 65
  • 8.4 PULSE OXIMETRY SCREENING TECHNOLOGY 66
  • 8.5 IMMUNOASSAYS AND ENZYMATIC ASSAYS 66
  • 8.6 ELECTROPHORESIS 67
  • 8.7 DNA-BASED ASSAYS 67

9 GLOBAL NEWBORN SCREENING MARKET, BY DISEASE TYPE 68

  • 9.1 OVERVIEW 69
  • 9.2 CRITICAL CONGENITAL HEART DISEASES 70
  • 9.3 NEWBORN HEARING LOSS 71
  • 9.4 SICKLE CELL DISEASE 72
  • 9.5 PHENYLKETONURIA (PKU) 73
  • 9.6 CYSTIC FIBROSIS (CF) 74
  • 9.7 MAPLE SYRUP URINE DISEASE 75
  • 9.8 OTHERS 76

10 GLOBAL NEWBORN SCREENING MARKET, BY END USER 77

  • 10.1 OVERVIEW 78
  • 10.2 HOSPITAL 79
  • 10.3 PEDIATRIC CLINICS 79
  • 10.4 CLINICS 80

11 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY 81

  • 11.1 OVERVIEW 82
  • 11.2 NORTH AMERICA 87
    • 11.2.1 U.S. 92
    • 11.2.2 CANADA 94
    • 11.2.3 MEXICO 96
  • 11.3 EUROPE 98
    • 11.3.1 GERMANY 104
    • 11.3.2 FRANCE 106
    • 11.3.3 U.K. 108
    • 11.3.4 SPAIN 110
    • 11.3.5 ITALY 112
    • 11.3.6 SWITZERLAND 114
    • 11.3.7 NETHERLANDS 116
    • 11.3.8 RUSSIA 118
    • 11.3.9 TURKEY 120
    • 11.3.10 BELGIUM 122
    • 11.3.11 REST OF EUROPE 124
  • 11.4 ASIA-PACIFIC 125
    • 11.4.1 JAPAN 131
    • 11.4.2 CHINA 133
    • 11.4.3 INDIA 135
    • 11.4.4 SOUTH KOREA 137
    • 11.4.5 AUSTRALIA 139
    • 11.4.6 SINGAPORE 141
    • 11.4.7 THAILAND 143
    • 11.4.8 MALAYSIA 145
    • 11.4.9 INDONESIA 147
    • 11.4.10 PHILIPPINES 149
    • 11.4.11 VIETNAM 151
    • 11.4.12 REST OF ASIA-PACIFIC 153
  • 11.5 SOUTH AMERICA 154
    • 11.5.1 BRAZIL 160
    • 11.5.2 REST OF SOUTH AMERICA 162
  • 11.6 MIDDILE EAST AND AFRICA 163
    • 11.6.1 SOUTH AFRICA 168
    • 11.6.2 REST OF MIDDLE EAST & AFRICA 170

12 GLOBAL NEWBORN SCREENING MARKET, COMPANY LANDSCAPE 171

  • 12.1 COMPANY SHARE ANALYSIS: GLOBAL 171
  • 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 172
  • 12.3 COMPANY SHARE ANALYSIS: EUROPE 173
  • 12.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC 174

13 COMPANY PROFILES 175

  • 13.1 PERKINELMER INC. 175
    • 13.1.1 COMPANY SNAPSHOT 175
    • 13.1.2 REVENUE ANALYSIS 175
    • 13.1.3 PRODUCT PORTFOLIO 176
    • 13.1.4 RECENT DEVELOPMENTS 180
  • 13.2 NATUS MEDICAL INCORPORATED 181
    • 13.2.1 COMPANY SNAPSHOT 181
    • 13.2.2 REVENUE ANALYSIS 181
    • 13.2.3 PRODUCT PORTFOLIO 182
    • 13.2.4 RECENT DEVELOPMENTS 182
  • 13.3 TRIVITRON HEALTHCARE 183
    • 13.3.1 COMPANY SNAPSHOT 183
    • 13.3.2 PRODUCT PORTFOLIO 183
    • 13.3.3 RECENT DEVELOPMENTS 184
  • 13.4 BAEBIES, INC. 185
    • 13.4.1 COMPANY SNAPSHOT 185
    • 13.4.2 PRODUCT PORTFOLIO 185
    • 13.4.3 RECENT DEVELOPMENTS 185
  • 13.5 BIO-RAD LABORATORIES, INC. 186
    • 13.5.1 COMPANY SNAPSHOT 186
    • 13.5.2 REVENUE ANALYSIS 186
    • 13.5.3 PRODUCT PORTFOLIO 187
    • 13.5.4 RECENT DEVELOPMENT 187
  • 13.6 DANAHER 188
    • 13.6.1 COMPANY SNAPSHOT 188
    • 13.6.2 REVENUE ANALYSIS 188
    • 13.6.3 PRODUCT PORTFOLIO 189
    • 13.6.4 RECENT DEVELOPMENT 189
  • 13.7 HILL-ROM SERVICES INC. 190
    • 13.7.1 COMPANY SNAPSHOT 190
    • 13.7.2 REVENUE ANALYSIS 190
    • 13.7.3 PRODUCT PORTFOLIO 191
    • 13.7.4 RECENT DEVELOPMENT 191
  • 13.8 INTELLIGENT HEARING SYSTEMS 192
    • 13.8.1 COMPANY SNAPSHOT 192
    • 13.8.2 PRODUCT PORTFOLIO 192
    • 13.8.3 RECENT DEVELOPMENT 192
  • 13.9 INTERACOUSTICS A/S 193
    • 13.9.1 COMPANY SNAPSHOT 193
    • 13.9.2 PRODUCT PORTFOLIO 193
    • 13.9.3 RECENT DEVELOPMENTS 194
  • 13.10 MASIMO 195
    • 13.10.1 COMPANY SNAPSHOT 195
    • 13.10.2 REVENUE ANALYSIS 195
    • 13.10.3 PRODUCT PORTFOLIO 196
    • 13.10.4 RECENT DEVELOPMENT 196
  • 13.11 MEDTRONIC 197
    • 13.11.1 COMPANY SNAPSHOT 197
    • 13.11.2 REVENUE ANALYSIS 197
    • 13.11.3 PRODUCT PORTFOLIO 198
    • 13.11.4 RECENT DEVELOPMENT 198
  • 13.12 OTODYNAMICS LTD 199
    • 13.12.1 COMPANY SNAPSHOT 199
    • 13.12.2 PRODUCT PORTFOLIO 199
    • 13.12.3 RECENT DEVELOPMENTS 200
  • 13.13 VIVASONIC INC. 201
    • 13.13.1 COMPANY SNAPSHOT 201
    • 13.13.2 PRODUCT PORTFOLIO 201
    • 13.13.3 RECENT DEVELOPMENTS 201
  • 13.14 ZENTECH S.A. 202
    • 13.14.1 COMPANY SNAPSHOT 202
    • 13.14.2 PRODUCT PORTFOLIO 202
    • 13.14.3 RECENT DEVELOPMENTS 203

14 QUESTIONNAIRE 204

15 RELATED REPORTS 207

LIST OF TABLES

LIST OF TABLES

UU

  • TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S. 36
  • TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018 38
  • TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016) 38
  • TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018) 39
  • TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018) 39
  • TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION) 43
  • TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION) 44
  • TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS 45
  • TABLE 9 GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 55
  • TABLE 10 GLOBAL DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 55
  • TABLE 11 GLOBAL HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 56
  • TABLE 12 GLOBAL CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 57
  • TABLE 13 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 59
  • TABLE 14 GLOBAL PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 60
  • TABLE 15 GLOBAL INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 60
  • TABLE 16 GLOBAL REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 61
  • TABLE 17 GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 63
  • TABLE 18 GLOBAL TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 64
  • TABLE 19 GLOBAL HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 65
  • TABLE 20 GLOBAL PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 66
  • TABLE 21 GLOBAL IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 66
  • TABLE 22 GLOBAL ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 67
  • TABLE 23 GLOBAL DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 67
  • TABLE 24 GLOBAL NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 69
  • TABLE 25 GLOBAL CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 70
  • TABLE 26 GLOBAL NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 71
  • TABLE 27 GLOBAL SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 72
  • TABLE 28 GLOBAL PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 73
  • TABLE 29 GLOBAL CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 74
  • TABLE 30 GLOBAL MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 75
  • TABLE 31 GLOBAL OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 76
  • TABLE 32 GLOBAL NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 78
  • TABLE 33 GLOBAL HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 79
  • TABLE 34 GLOBAL PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 79
  • TABLE 35 GLOBAL CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 80
  • TABLE 36 GLOBAL NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 86
  • TABLE 37 NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 90
  • TABLE 38 NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 90
  • TABLE 39 NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 90
  • TABLE 40 NORTH AMERICA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 90
  • TABLE 41 NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 91
  • TABLE 42 NORTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 91
  • TABLE 43 NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 91
  • TABLE 44 U.S. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 92
  • TABLE 45 U.S. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 92
  • TABLE 46 U.S. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 92
  • TABLE 47 U.S. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 93
  • TABLE 48 U.S. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 93
  • TABLE 49 U.S. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 93
  • TABLE 50 CANADA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 94
  • TABLE 51 CANADA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 94
  • TABLE 52 CANADA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 94
  • TABLE 53 CANADA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 95
  • TABLE 54 CANADA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 95
  • TABLE 55 CANADA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 95
  • TABLE 56 MEXICO NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 96
  • TABLE 57 MEXICO NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 96
  • TABLE 58 MEXICO INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 96
  • TABLE 59 MEXICO NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 97
  • TABLE 60 MEXICO NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 97
  • TABLE 61 MEXICO NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 97
  • TABLE 62 EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 101
  • TABLE 63 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 101
  • TABLE 64 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 101
  • TABLE 65 EUROPE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 102
  • TABLE 66 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 102
  • TABLE 67 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 102
  • TABLE 68 EUROPE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 103
  • TABLE 69 GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 104
  • TABLE 70 GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 104
  • TABLE 71 GERMANY INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 104
  • TABLE 72 GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 105
  • TABLE 73 GERMANY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 105
  • TABLE 74 GERMANY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 105
  • TABLE 75 FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 106
  • TABLE 76 FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 106
  • TABLE 77 FRANCE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 106
  • TABLE 78 FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 107
  • TABLE 79 FRANCE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 107
  • TABLE 80 FRANCE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 107
  • TABLE 81 U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 108
  • TABLE 82 U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 108
  • TABLE 83 U.K. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 108
  • TABLE 84 U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 109
  • TABLE 85 U.K. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 109
  • TABLE 86 U.K. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 109
  • TABLE 87 SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 110
  • TABLE 88 SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 110
  • TABLE 89 SPAIN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 110
  • TABLE 90 SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 111
  • TABLE 91 SPAIN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 111
  • TABLE 92 SPAIN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 111
  • TABLE 93 ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 112
  • TABLE 94 ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 112
  • TABLE 95 ITALY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 112
  • TABLE 96 ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 113
  • TABLE 97 ITALY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 113
  • TABLE 98 ITALY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 113
  • TABLE 99 SWITZERLAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 114
  • TABLE 100 SWITZERLAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 114
  • TABLE 101 SWITZERLAND INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 114
  • TABLE 102 SWITZERLAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 115
  • TABLE 103 SWITZERLAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 115
  • TABLE 104 SWITZERLAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 115
  • TABLE 105 NETHERLANDS NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 116
  • TABLE 106 NETHERLANDS NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 116
  • TABLE 107 NETHERLANDS INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 116
  • TABLE 108 NETHERLANDS NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 117
  • TABLE 109 NETHERLANDS NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 117
  • TABLE 110 NETHERLANDS NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 117
  • TABLE 111 RUSSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 118
  • TABLE 112 RUSSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 118
  • TABLE 113 RUSSIA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 118
  • TABLE 114 RUSSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 119
  • TABLE 115 RUSSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 119
  • TABLE 116 RUSSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 119
  • TABLE 117 TURKEY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 120
  • TABLE 118 TURKEY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 120
  • TABLE 119 TURKEY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 120
  • TABLE 120 TURKEY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 121
  • TABLE 121 TURKEY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 121
  • TABLE 122 TURKEY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 121
  • TABLE 123 BELGIUM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 122
  • TABLE 124 BELGIUM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 122
  • TABLE 125 BELGIUM INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 122
  • TABLE 126 BELGIUM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 123
  • TABLE 127 BELGIUM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 123
  • TABLE 128 BELGIUM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 123
  • TABLE 129 REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 124
  • TABLE 130 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 128
  • TABLE 131 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 128
  • TABLE 132 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 128
  • TABLE 133 ASIA-PACIFIC INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 129
  • TABLE 134 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 129
  • TABLE 135 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 129
  • TABLE 136 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 130
  • TABLE 137 JAPAN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 131
  • TABLE 138 JAPAN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 131
  • TABLE 139 JAPAN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 131
  • TABLE 140 JAPAN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 132
  • TABLE 141 JAPAN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 132
  • TABLE 142 JAPAN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 132
  • TABLE 143 CHINA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 133
  • TABLE 144 CHINA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 133
  • TABLE 145 CHINA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 133
  • TABLE 146 CHINA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 134
  • TABLE 147 CHINA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 134
  • TABLE 148 CHINA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 134
  • TABLE 149 INDIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 135
  • TABLE 150 INDIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 135
  • TABLE 151 INDIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 135
  • TABLE 152 INDIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 136
  • TABLE 153 INDIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 136
  • TABLE 154 INDIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 136
  • TABLE 155 SOUTH KOREA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 137
  • TABLE 156 SOUTH KOREA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 137
  • TABLE 157 SOUTH KOREA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 137
  • TABLE 158 SOUTH KOREA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 138
  • TABLE 159 SOUTH KOREA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 138
  • TABLE 160 SOUTH KOREA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 138
  • TABLE 161 AUSTRALIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 139
  • TABLE 162 AUSTRALIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 139
  • TABLE 163 AUSTRALIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 139
  • TABLE 164 AUSTRALIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 140
  • TABLE 165 AUSTRALIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 140
  • TABLE 166 AUSTRALIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 140
  • TABLE 167 SINGAPORE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 141
  • TABLE 168 SINGAPORE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 141
  • TABLE 169 SINGAPORE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 141
  • TABLE 170 SINGAPORE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 142
  • TABLE 171 SINGAPORE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 142
  • TABLE 172 SINGAPORE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 142
  • TABLE 173 THAILAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 143
  • TABLE 174 THAILAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 143
  • TABLE 175 THAILAND INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 143
  • TABLE 176 THAILAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 144
  • TABLE 177 THAILAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 144
  • TABLE 178 THAILAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 144
  • TABLE 179 MALAYSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 145
  • TABLE 180 MALAYSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 145
  • TABLE 181 MALAYSIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 145
  • TABLE 182 MALAYSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 146
  • TABLE 183 MALAYSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 146
  • TABLE 184 MALAYSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 146
  • TABLE 185 INDONESIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 147
  • TABLE 186 INDONESIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 147
  • TABLE 187 INDONESIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 147
  • TABLE 188 INDONESIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 148
  • TABLE 189 INDONESIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 148
  • TABLE 190 INDONESIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 148
  • TABLE 191 PHILIPPINES NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 149
  • TABLE 192 PHILIPPINES NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 149
  • TABLE 193 PHILIPPINES INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 149
  • TABLE 194 PHILIPPINES NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 150
  • TABLE 195 PHILIPPINES NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 150
  • TABLE 196 PHILIPPINES NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 150
  • TABLE 197 VIETNAM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 151
  • TABLE 198 VIETNAM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 151
  • TABLE 199 VIETNAM INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 151
  • TABLE 200 VIETNAM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 152
  • TABLE 201 VIETNAM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 152
  • TABLE 202 VIETNAM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 152
  • TABLE 203 REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 153
  • TABLE 204 SOUTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 157
  • TABLE 205 SOUTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 157
  • TABLE 206 SOUTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 157
  • TABLE 207 SOUTH AMERICA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 157
  • TABLE 208 SOUTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 158
  • TABLE 209 SOUTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 158
  • TABLE 210 SOUTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 159
  • TABLE 211 BRAZIL NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 160
  • TABLE 212 BRAZIL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 160
  • TABLE 213 BRAZIL INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 160
  • TABLE 214 BRAZIL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 161
  • TABLE 215 BRAZIL NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 161
  • TABLE 216 BRAZIL NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 161
  • TABLE 217 REST OF SOUTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 162
  • TABLE 218 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 166
  • TABLE 219 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 166
  • TABLE 220 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 166
  • TABLE 221 MIDDLE EAST AND AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 166
  • TABLE 222 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 167
  • TABLE 223 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 167
  • TABLE 224 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 167
  • TABLE 225 SOUTH AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 168
  • TABLE 226 SOUTH AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 168
  • TABLE 227 SOUTH AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 168
  • TABLE 228 SOUTH AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 169
  • TABLE 229 SOUTH AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 169
  • TABLE 230 SOUTH AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 169
  • TABLE 231 REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 170

LIST OF FIGURES

LIST OF FIGURES

  • FIGURE 1 GLOBAL NEWBORN SCREENING MARKET: SEGMENTATION 26
  • FIGURE 2 GLOBAL NEWBORN SCREENING MARKET: DATA TRIANGULATION 29
  • FIGURE 3 GLOBAL NEWBORN SCREENING MARKET: RESEARCH SNAPSHOT 30
  • FIGURE 4 GLOBAL NEWBORN SCREENING MARKET: GLOBAL VS. REGIONAL ANALYSIS 31
  • FIGURE 5 GLOBAL NEWBORN SCREENING MARKET: COMPANY RESEARCH ANALYSIS 31
  • FIGURE 6 GLOBAL NEWBORN SCREENING MARKET: INTERVIEW DEMOGRAPHICS 32
  • FIGURE 7 DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL NEWBORN SCREENING MARKET 35
  • FIGURE 8 NEONATAL MORTALITY RATE (PER 1000 LIVE BIRTHS) (2010-2016) 37
  • FIGURE 9 NEONATAL MORTALITY RATE (PER 1000 LIVE BIRTHS) (2010-2017) 37
  • FIGURE 10 VARIOUS CAUSES OF NEONATAL DEATH WORLDWIDE EACH YEAR 39
  • FIGURE 11 HEALTH CARE EXPENDITURE (USD MILLION) 45
  • FIGURE 12 GLOBAL NEWBORN SCREENING MARKET: SEGMENTATION 48
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL NEWBORN SCREENING MARKET AND ASIA- PACIFIC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026 49
  • FIGURE 14 GROWTH IN NEONATAL DISEASES IS EXPECTED TO DRIVE THE MARKET FOR NEWBORN SCREENING IN THE FORECAST PERIOD OF 2019 TO 2026 50
  • FIGURE 15 DRIED BLOOD SPOT TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEWBORN SCREENING MARKET IN 2019 51
  • FIGURE 16 ASIA-PACIFIC IS THE HIGHEST GROWING AND NORTH AMERICA MOST PROFITABLE REVENUE POCKETS FOR GLOBAL NEWBORN SCREENING MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 52
  • FIGURE 17 GLOBAL NEWBORN SCREENING MARKET: BY TEST TYPE, 2018 54
  • FIGURE 18 GLOBAL NEWBORN SCREENING MARKET: BY PRODUCT TYPE, 2018 59
  • FIGURE 19 GLOBAL NEWBORN SCREENING MARKET: BY TECHNOLOGY, 2018 63
  • FIGURE 20 GLOBAL NEWBORN SCREENING MARKET: BY DISEASE TYPE, 2018 69
  • FIGURE 21 GLOBAL NEWBORN SCREENING MARKET: BY END USER, 2018 78
  • FIGURE 22 GLOBAL NEWBORN SCREENING MARKET: SNAPSHOT (2018) 83
  • FIGURE 23 GLOBAL NEWBORN SCREENING MARKET: BY GEOGRAPHY (2018) 84
  • FIGURE 24 GLOBAL NEWBORN SCREENING MARKET: BY GEOGRAPHY (2019 & 2026) 84
  • FIGURE 25 GLOBAL NEWBORN SCREENING MARKET: BY GEOGRAPHY (2018 & 2026) 85
  • FIGURE 26 GLOBAL NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026) 85
  • FIGURE 27 NORTH AMERICA NEWBORN SCREENING MARKET: SNAPSHOT (2018) 87
  • FIGURE 28 NORTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2018) 88
  • FIGURE 29 NORTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2019 & 2026) 88
  • FIGURE 30 NORTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2018 & 2026) 89
  • FIGURE 31 NORTH AMERICA NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026) 89
  • FIGURE 32 EUROPE NEWBORN SCREENING MARKET: SNAPSHOT (2018) 98
  • FIGURE 33 EUROPE NEWBORN SCREENING MARKET: BY COUNTRY (2018) 99
  • FIGURE 34 EUROPE NEWBORN SCREENING MARKET: BY COUNTRY (2019 & 2026) 99
  • FIGURE 35 EUROPE NEWBORN SCREENING MARKET: BY COUNTRY (2018 & 2026) 100
  • FIGURE 36 EUROPE NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026) 100
  • FIGURE 37 ASIA-PACIFIC NEWBORN SCREENING MARKET: SNAPSHOT (2018) 125
  • FIGURE 38 ASIA-PACIFIC NEWBORN SCREENING MARKET: BY COUNTRY (2018) 126
  • FIGURE 39 ASIA-PACIFIC NEWBORN SCREENING MARKET: BY COUNTRY (2019 & 2026) 126
  • FIGURE 40 ASIA-PACIFIC NEWBORN SCREENING MARKET: BY COUNTRY (2018 & 2026) 127
  • FIGURE 41 ASIA-PACIFIC NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026) 127
  • FIGURE 42 SOUTH AMERICA NEWBORN SCREENING MARKET: SNAPSHOT (2018) 154
  • FIGURE 43 SOUTH AMERICAN EWBORN SCREENING MARKET: BY COUNTRY (2018) 155
  • FIGURE 44 SOUTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2019 & 2026) 155
  • FIGURE 45 SOUTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2018 & 2026) 156
  • FIGURE 46 SOUTH AMERICA NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026) 156
  • FIGURE 47 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET: SNAPSHOT (2018) 163
  • FIGURE 48 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET: BY COUNTRY (2018) 164
  • FIGURE 49 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET: BY COUNTRY (2019 & 2026) 164
  • FIGURE 50 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET: BY COUNTRY (2018 & 2026) 165
  • FIGURE 51 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026) 165
  • FIGURE 52 GLOBAL NEWBORN SCREENING MARKET: COMPANY SHARE 2017 (%) 171
  • FIGURE 53 NORTH AMERICA NEWBORN SCREENING MARKET: COMPANY SHARE 2017 (%) 172
  • FIGURE 54 EUROPE NEWBORN SCREENING MARKET: COMPANY SHARE 2017 (%) 173
  • FIGURE 55 ASIA PACIFIC NEWBORN SCREENING MARKET: COMPANY SHARE 2017 (%) 174
Back to Top